Determining the effective dose of bupivacaine for labor pain relief
Official title: A Trial to Determine the Optimal Bupivacaine Dose for Initiation of Labor Epidural Pain Relief With a Lidocaine Test Dose
Run by Brigham and Women's Hospital · NCT06146842 · Data updated 2026-11-12
This study is testing how much bupivacaine is needed to effectively relieve pain for women in labor after they receive a test dose of lidocaine.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Sex | Women only |
| Enrollment | 120 (estimated) |
| Sponsor | Brigham and Women's Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | December 1, 2023 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | July 13, 2026 |
| Trial ID | NCT06146842 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include pregnant women at term with no major co-morbidities who desire epidural labor analgesia.
✕Probably not a fit
Patients with significant medical conditions or contraindications to epidural techniques will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to estimate the effective dose of bupivacaine needed for pain relief in women undergoing labor induction or augmentation after a lidocaine test dose. It employs a randomized controlled trial design with participants assigned to either the DPE or EPL technique. The initial dose of bupivacaine is set at 25 mg, and subsequent doses are adjusted based on the responses of previous subjects using a biased coin up-down allocation method. The goal is to achieve a pain score of less than 3 on a numerical rating scale within 30 minutes of administration.
Why it matters
Potential benefit: If successful, this study could optimize pain management during labor, leading to improved comfort for patients.
How similar studies have gone: Other studies have successfully utilized similar methodologies to determine effective analgesic doses, suggesting this approach is promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Parturient with no major co-morbidities 2. Singleton, vertex gestation at term (37-42 weeks) 3. Less than or equal to 5 cm dilation 4. Desire to receive epidural labor analgesia 5. Numerical Rating Scale greater than or equal to 5 (NRS 0-10, where 0 = no pain, and 10 = worst pain imaginable), at time of epidural labor analgesia request. Exclusion Criteria: 1. Current or historical evidence of clinically significant disease or condition, including diseases of pregnancy (i.e., preeclampsia, gestational diabetes) 2. Any contraindication to the administration of an epidural technique (e.g., thrombocytopenia, antiplatelet meds). 3. History of hypersensitivity or idiosyncratic reaction to an amide local anesthetic agent 4. Evidence of anticipated fetal complications (i.e., fetal anomalies, IUGR (Intrauterine Growth Restriction), oligohydramnios, polyhydramnios)
Where it's running
-
Brigham and Women's Hospital
Boston, Massachusetts, United States Recruiting
Study contacts
- Study coordinator: Lawrence Tsen, MD
- Email: ltsen@bwh.harvard.edu
- Phone: 617-732-8216
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dural Puncture Epidural (DPE) Technique in Labor Analgesia
This observational study at Ohio State tests whether the DPE method can reliably reveal CSF and improve epidural placement during labor without injecting medication.
-
Midwife-guided Birth Affirmation Cards for Primigravidas
This study tests whether midwife-guided birth affirmation cards can shorten labor, reduce pain, and improve feelings of control and support for first-time mothers.
-
Tramadol versus paracetamol versus placebo for pain relief and labor length in first-time mothers
This trial will try IV tramadol, IV paracetamol, or saline to see which gives better pain relief and changes active labor length for first-time mothers in active labor.
-
Left-side versus lying on your back to shorten the active phase of labor
This trial tests whether staying on your left side instead of lying on your back shortens the active phase of labor for first-time mothers at term.
-
TENS for pain relief during active labor
This trial will try using a TENS device versus a sham to see if it lowers pain for first-time moms during the active phase of labor.
-
PIEB versus CEI for epidural labor pain relief
This trial will test whether programmed intermittent epidural boluses (PIEB) or a continuous epidural infusion (CEI), each combined with patient-controlled epidural analgesia (PCEA), works better for pain relief during labor in women having vaginal delivery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.